City Holding reports record Q3 2026 EPS of $2.43 and $34.6 million in net income as net interest margin rises to 4.04% and ...

Acumen reports a $25.4 million Q3 loss and $78.6 million in cash as it prepares to release Phase 2 sabirnetug Alzheimer's ...

Verizon reports Q3 revenue of $34.3 billion, adds 406,000 postpaid phone customers and raises 2026 guidance while signing a $2B+ AWS AI deal.

Enanta doses the first patient in its Phase 2b/3 RESOLVE RSV trial of zelicapavir in high-risk adults, with initial topline ...

Genmab reports 28.2-month median survival and 63% response rate with petosemtamab plus pembrolizumab in Phase 2 head and neck ...

Ovintiv agrees to acquire Logan Energy for about $890 million, adding 266,000 net acres and targeting $60 million in annual ...

Eikon reports a 63.1% response rate in its Phase 2 EIK1001 lung cancer trial, with 89.2% disease control and a Phase 2/3 study underway.

Amanat and Corxel plan a $377 million business combination to fund CX11 Phase 3 obesity trials, targeting a closing in the ...

BioNTech and DualityBio report modest Phase 3 breast cancer benefit with trastuzumab pamirtecan, but higher lung disease ...

HUTCHMED reports 24.9-month progression-free survival with ORPATHYS plus TAGRISSO versus 13.8 months in its Phase III SANOVO ...

HBT Financial reports Q3 2026 net income of $31.4 million, EPS of $0.86 and a 4.35% net interest margin, ahead of its planned ...

Elbit Systems wins $200 million in Asia-Pacific contracts for SPECTRO 12 helicopter sensors, airborne training upgrades and cockpit displays ...